The Canadian Cannabis Story

Total Page:16

File Type:pdf, Size:1020Kb

The Canadian Cannabis Story A Generational Investment Opportunity THE CANADIAN CANNABIS STORY JOIN THE CONVERSATION / Echelon Wealth Partners echelonpartners.com TABLE OF CONTENTS 3 The Canadian Cannabis Story: A Generational Investment Opportunity 4 Cannabis: A Brief History 5 The Many Forms of Cannabis 5 An Increase in Legal Cannabis-based Products 5 Medical Use 8 Cannabis as an Opiod Alternative 11 Cannabis and Canada: A Strong Growth Story 14 A Global Cannabis Boom: The Next Stage 17 Canadian Cannabis Stocks - An Investment Opportunity to Consider 19 Endnotes echelonpartners.com 2 The Canadian Cannabis Story: A Generational Investment Opportunity THE CANADIAN CANNABIS STORY: A GENERATIONAL INVESTMENT OPPORTUNITY By Echelon Wealth Partners The Canadian Cannabis Story aims to provide readers with a comprehensive look at the cannabis market in Canada through its history, growth, and various production sectors to illuminate the investment opportunity this sector will afford in a rapidly growing global market. The increasing trend in cannabis decriminalization and legalization, both in North America and around the world, has awakened the interest of the investment community. The unique and potential medicinal properties of cannabis and its versatility for other commercial uses are considered the harbingers of an investment with significant growth potential. Canada legalized marijuana for recreational use on October 17, 2018 echelonpartners.com 3 The Canadian Cannabis Story: A Generational Investment Opportunity CANNABIS A Brief History Marijuana is produced from the flower and leaves of cannabis plants, which grow naturally in humid temperate conditions on all continents.1 The two most important varieties of the cannabis plant are sativa and indica, with hemp being a specific species of the sativa plant. The first documented use of cannabis as a medicine and textile fibre dates back to China in 4000 B.C.2 The use of cannabis as a recreational drug (both in its herbal form, known as marijuana, and in its resin form, known as hashish) dates back to Persia in the seventh century.3 Use of cannabis for the production of textiles, pharmaceuticals, oil, and paper remained popular in the United States and Europe up to the 19th century. A prohibitionist trend began in the 20th century as more countries increasingly began to view cannabis use as a threat to social cohesion and some economic sectors. A ban in Greece in 1890 was followed by others in France (1916), Canada (1923), Great Britain (1928), and Australia (1938). Various U.S. states made recreational use illegal between 1915 and 1930 (among them Massachusetts in 1911 and California in 1915), with a federal ban eventually coming into force in 1937. Today, Canada’s licensed cannabis producers grow cannabis in indoor facilities, greenhouses and recently, even outdoors.4 The key difference between the two relates to climate control and the associated costs. Indoor facilities typically allow the producer to exercise more control over the growing conditions, but this often (though not always) translates into higher costs. Greenhouses have the benefit of lower costs for lighting but are then more dependent on local weather conditions, and the amount of sunlight in particular. There is still much debate as to which method is more profitable, but we have noticed that several cannabis companies that began their lives as indoor producers have expanded into greenhouse production.5 echelonpartners.com 4 The Canadian Cannabis Story: A Generational Investment Opportunity • Delta-9 Tetrahydrocannabinol (THC), the legislation between 1999 and 2011. The move- psycho-active chemical in cannabis, may slow the ment continued to grow, gaining particular THE MANY FORMS OF CANNABIS progression of Alzheimer’s disease;13 momentum in the last five years. In 2012 Colorado and Washington both legalized recreational use, • Cannabis may ease the symptoms and pain followed by Alaska, Oregon, and Washington D.C. 14 An Increase in Legal Cannabis-based Products associated with arteriosclerosis; in 2013. A further seven states legalized recre- ational use between 2013 and 2017, in addition to • Cannabis reduces muscle spasms, including 11 states permitting medical cannabis during the Once cannabis has been grown and harvested, it can be sold as ‘dried diaphragm spasms;15 same period.21 cannabis’ that consumers can either smoke or vape. Alternatively, it can be further processed into cannabis extract that can be used as the primary • Cannabis reduces the side effects and improves As of June 30, 2018, over 330,758 Canadians had ingredient in making a host of other products. the effectiveness of Hepatitis-C treatment;16 registered with Health Canada as users of canna- bis for medical purposes.21 That number has The industry is continuing to develop and commercialize more products that • THC and CBD can improve stomach function and grown dramatically over the past three years, and use cannabis as a major ingredient, with the federal government committed reduce the symptoms of Crohn’s disease;17 recent data suggests another 10,000+ new to broadening the field of legal products, including the addition of edibles patients are registering each month. (e.g., brownies, cookies, and gummies) and beverages within a year of the • Cannabis alleviates the pain and decreases the legalization of recreational use. inflammation associated with rheumatoid arthritis;18 • Cannabis may improve metabolic rate and insulin Medical Use levels, aiding fat loss;19 • Cannabis may reduce the symptoms of auto- The number one reason that physicians currently prescribe cannabis is for immune diseases.20 ppainain mmanagement.anagement.6 OOtherther mmajorajor uusesses iincludenclude mmanaginganaging nanauseausea ((e.g.,e.g., patpatientsients uundergoingndergoing chemchemotherapy),otherapy), anoanorexia,rexia, and post-traumatpost-traumaticic strstressess By the 1970s, a movement to reintroduce cannabis disorder (PTSD). use for medical purposes, supported by patients and medical professionals, began to take hold in the TThehe ppopularityopularity of cannabcannabis-basedis-based ppharmaceuticalsharmaceuticals iinn the 119th9th anandd 220th0th U.S. In 1996 California was the first state to legalize ccenturiesenturies wwasas a rresultesult of ththee mmanyany mmedicaledical ppropertiesroperties aattributedttributed ttoo iit,t, medical cannabis as a painkiller for cancer and especiallyespecially as a remedy fforor paipain,n, insoinsomnia,mnia, anandd hheadaches.eadaches. The sstatustatus of AIDS. Alaska, Oregon, and Washington followed cannabiscannabis aass a SSchedulechedule I subsubstance,stance, whiwhichch iiss dedefinedfined as hhavingaving nnoo suit in 1998. A further 13 states enacted similar therapeutictherapeutic valvalueue aandnd hhavingaving a high ppotentialotential fforor aabuse,buse, by tthehe FFederalederal government in 1970, has severely limited scientific research efforts.7 Some studies have nevertheless indicated potential benefits through the years: • Cannabis can treat glaucoma by lowering intra-ocular pressure;8 • Smoking cannabis may improve lung capacity and functioning;9 • Cannabis can help eliminate epileptic seizures;10 • CannabidiolCannabidiol (CBD(CBD),), aann acactivetive chchemicalemical iinn cacannabis,nnabis, mamayy sstoptop tthehe reproduction and spread of cancer cells;11 • Cannabis can be helpful in reducing the symptoms of anxiety;12 echelonpartners.com 5 The Canadian Cannabis Story: A Generational Investment Opportunity • Delta-9 Tetrahydrocannabinol (THC), the legislation between 1999 and 2011. The move- psycho-active chemical in cannabis, may slow the ment continued to grow, gaining particular progression of Alzheimer’s disease;13 momentum in the last five years. In 2012 Colorado and Washington both legalized recreational use, • Cannabis may ease the symptoms and pain followed by Alaska, Oregon, and Washington D.C. associated with arteriosclerosis;14 in 2013. A further seven states legalized recre- ational use between 2013 and 2017, in addition to • Cannabis reduces muscle spasms, including 11 states permitting medical cannabis during the diaphragm spasms;15 same period.21 • Cannabis reduces the side effects and improves As of June 30, 2018, over 330,758 Canadians had the effectiveness of Hepatitis-C treatment;16 registered with Health Canada as users of canna- bis for medical purposes.21 That number has • THC and CBD can improve stomach function and grown dramatically over the past three years, and reduce the symptoms of Crohn’s disease;17 recent data suggests another 10,000+ new patients are registering each month. • Cannabis alleviates the pain and decreases the inflammation associated with rheumatoid arthritis;18 • Cannabis may improve metabolic rate and insulin levels, aiding fat loss;19 • Cannabis may reduce the symptoms of auto- immune diseases.20 By the 1970s, a movement to reintroduce cannabis use for medical purposes, supported by patients and medical professionals, began to take hold in the U.S. In 1996 California was the first state to legalize medical cannabis as a painkiller for cancer and AIDS. Alaska, Oregon, and Washington followed suit in 1998. A further 13 states enacted similar IS THE ANNUAL COMPOUND GROWTH IN CANADIAN USERS OF MEDICAL MARIJUANA FROM 2014 TO 2018. echelonpartners.com 6 The Canadian Cannabis Story: A Generational Investment Opportunity CANADIAN MEDICAL CANNABIS TOTAL REGISTERED USERS 330,758 300,000 296,702 269,502 250,000 235,621 201,398 200,000 167,754 150,000 129,876 98,460 100,000 75,166 50,000 39,668
Recommended publications
  • Appendix 1 (As Supplied by the Authors)
    Appendix 1 (as supplied by the authors): Sources of information regarding how each Canadian province and territory is allowing cannabis retail and online sales, and store locations Jurisdiction Source Store locations Provinces Newfoundland and Labrador Legislation: Bill 20: An Act Clarenville Green Stop (Esso), Clarenville, 258 Memorial Drive, Respecting the Control and Sale A5A1N9 of Cannabis1 C-Shop, Bay Roberts, 230 Conception Bay Highway, A0A1G0 Regulations: Newfoundland and C-Shop, Carbonear, 120 Columbus Drive, A1Y1B3 Labrador Cannabis Regulations2 C-Shop, Conception Bay South, 166 Conception Bay Highway, A1W3A6 List of Retail Stores: Store C-Shop, Corner Brook, 5 Murphy Square, A2H1R4 Locator (Cannabis NL)3 C-Shop, Gander, 100 Laurell Road, A1V2V5 Online Store: Cannabis NL4 C-Shop, Grand Falls-Windsor, 17 Cromer Ave, A2A1X3 C-Shop, Mount Pearl, 150 Old Placentia Road, A1N4Y9 C-shop, St. John's, 260 Blackmarsh Road, A1E1T2 C-shop, St. John's, 55 Stavanger Drive, A1A5E8 C-Shop, Stephenville, 62 Prince Rupert Drive, A2N3W7 Deer Lake Green Stop, Deer Lake, 31 Upper Nicholsville Rd, A8A2G1 High North, Labrador City, 1 Neal Drive, A2V1Y5 Miawpukek Cannabis Boutique, Conne River, 19 Miawpukek Drive, A0H1J0 Paradise Green Stop, Paradise, 1316 Topsail Rd, A1L1N9 The Herbal Centre, St. John's, 394 Kenmount Road, A1B3R2 The Natural Vibe, St. John's, 306 Water Street, A1C1B8 The Reef Cannabis Shop, Holyrood, 386 CBS Highway, A0A2R0 Thomas H. Clarke's Distribution, Portugal Cove - St. Phillips, 1614 Portugal Cove Road, A1M3G3 Tweed, Conception Bay, 81 Conception Bay Highway S Unit 3, A1W3A3 Tweed, Corner Brook, 62 Broadway Avenue, A2H6H4 Tweed, Happy Valley-Goose Bay, 27 Aspen Drive, A0P1C0 Tweed, Mount Pearl, 50 Commonwealth Ave Unit 5, A1N1X1 Tweed, St.
    [Show full text]
  • Initial Considerations for the Creation of an Inter-Regional Industrial Hemp Value Chain Between Malawi and South Africa
    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Lowitt, Sandy Working Paper Initial considerations for the creation of an inter- regional industrial hemp value chain between Malawi and South Africa WIDER Working Paper, No. 2020/23 Provided in Cooperation with: United Nations University (UNU), World Institute for Development Economics Research (WIDER) Suggested Citation: Lowitt, Sandy (2020) : Initial considerations for the creation of an inter- regional industrial hemp value chain between Malawi and South Africa, WIDER Working Paper, No. 2020/23, ISBN 978-92-9256-780-4, The United Nations University World Institute for Development Economics Research (UNU-WIDER), Helsinki, http://dx.doi.org/10.35188/UNU-WIDER/2020/780-4 This Version is available at: http://hdl.handle.net/10419/229247 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte.
    [Show full text]
  • Programme & Abstracts
    The 57th Annual Meeting of the International Association of Forensic Toxicologists. 2nd - 6th September 2019 BIRMINGHAM, UK The ICC Birmingham Broad Street, Birmingham B1 2EA Programme & Abstracts 1 Thank You to our Sponsors PlatinUm Gold Silver Bronze 2 3 Contents Welcome message 5 Committees 6 General information 7 iCC maps 8 exhibitors list 10 Exhibition Hall 11 Social Programme 14 opening Ceremony 15 Schedule 16 Oral Programme MONDAY 2 September 19 TUESDAY 3 September 21 THURSDAY 5 September 28 FRIDAY 6 September 35 vendor Seminars 42 Posters 46 oral abstracts 82 Poster abstracts 178 4 Welcome Message It is our great pleasure to welcome you to TIAFT Gala Dinner at the ICC on Friday evening. On the accompanying pages you will see a strong the UK for the 57th Annual Meeting of scientific agenda relevant to modern toxicology and we The International Association of Forensic thank all those who submitted an abstract and the Toxicologists Scientific Committees for making the scientific programme (TIAFT) between 2nd and 6th a success. Starting with a large Young Scientists September 2019. Symposium and Dr Yoo Memorial plenary lecture by Prof Tony Moffat on Monday, there are oral session topics in It has been decades since the Annual Meeting has taken Clinical & Post-Mortem Toxicology on Tuesday, place in the country where TIAFT was founded over 50 years Human Behaviour Toxicology & Drug-Facilitated Crime on ago. The meeting is supported by LTG (London Toxicology Thursday and Toxicology in Sport, New Innovations and Group) and the UKIAFT (UK & Ireland Association of Novel Research & Employment/Occupational Toxicology Forensic Toxicologists) and we thank all our exhibitors and on Friday.
    [Show full text]
  • Rockledge City Council Regular Meeting Notice and Agenda
    ROCKLEDGE CITY COUNCIL REGULAR MEETING NOTICE AND AGENDA Wednesday, February 1, 2017 - 6:00 p.m. Chairman Thomas J. Price Presiding Council Chamber, Rockledge City Hall, 1600 Huntington Lane, Rockledge, FL 32955 *~*~*~*~*~*~* EVERY PERSON ADDRESSING THE CITY COUNCIL MUST COMPLETE A SPEAKER'S CARD The cards are located near the door of the Council Chamber. Completed cards are to be given to the City Clerk before the meeting convenes or prior to the introduction of a particular agenda item. *~*~*~*~*~*~* 1. CALL TO ORDER / ROLL CALL 2. INVOCATION l Councilman Hartselle 3. SALUTE TO THE FLAG 4. APPROVAL OF MINUTES l Regular Meeting on January 18, 2017 Documents: COUNCIL MINUTES 2017 01-18.PDF 5. PRESENTATIONS A. Mayor Price 1. Certificate Of Completion To Councilman Daski: 2016 Florida League Of Cities Advanced Institute For Elected Municipal Officials B. Public Works Director Poole 1. Video: Know Your Waterways 6. FINANCIAL / BUDGET REPORT l None 7. PUBLIC HEARINGS / ORDINANCES / RESOLUTIONS A. Resolution: Providing for the Apportionment of $4.00 of the $14.00 Base Sewer Service Charge Documents: 2017- RESOLUTION SEWER CHARGE APPORTIONMENT.PDF B. Public Hearing: VE-17-01, Vacate Public Utility Easement, Lots 25, 26, 27 and 28, Angela Avenue, Casa Loma Subdivision Documents: PUBLIC HEARING NOTICE VACATE EASEMENT PORTION OF ANGELA AVE CASA LOMA SUBDIVSION.PDF C. Resolution: Vacating Public Utility Easement, Lots 25, 26, 27 and 28, Angela Avenue, Casa Loma Subdivision Documents: 2017- RESOLUTION VACATING EASEMENT, CASA LOMA SUBDIVISION BLOCK A (VE-17-01, RJM MERCO).PDF D. Ordinance: First Reading, Relating to Cannabis Dispensing Facilities and Imposing a Temporary Moratorium on the Opening of Any New Cannabis Dispensing Facility Documents: ORDINANCE NO.
    [Show full text]
  • Cannabis in Canada: What the Upcoming Legalization of One of Canada’S Most Popular Drugs Means for Young People Braedon R
    LETTER Cannabis in Canada: What the upcoming legalization of one of Canada’s most popular drugs means for young people Braedon R. Paul1 Citation: UBCMJ. 2018: 9.2 (40-41) ith the Canadian legalization and regulation of cannabis slated term, some have shown residual effects lasting well beyond abstinence Wfor a debut no later than July 2018,1 many Canadians are eagerly of cannabis use,14 particularly if chronic and heavy use was initiated in awaiting the day when one of Canada’s most popular drugs2,3 can be earlier adolescence. Additionally, chronic use of smoked cannabis has legally purchased and consumed for recreational purposes. Bill C-45 been associated with symptoms of chronic bronchitis and large airway [the Cannabis Act], introduced to the House of Commons in early inflammation, while the links between smoking cannabis and lung 2017,4 is set to legalize and regulate the production, distribution, and cancer have been suggested by some but not conclusively determined.15 sale of recreational cannabis across Canada, fulfilling an election If the age limit is set too high, however, illicit sales from organized promise made by the Liberal Party of Canada [LPOC] in 2015.5 crime groups, which currently reap an estimated $7 billion annually Although many are in favour of the incoming legislation, an equally in Canada alone,16 will continue to supply the underage market—a vocal group has expressed concern over its pitfalls, particularly those substantial concern given that Canadian youth are understood to be regarding the potential impacts on Canadian youth. Given what is the highest young users of cannabis in the world3 and are more than currently understood about the effects of cannabis usage on adolescent double that of the general Canadian population.2 Inevitably, such high health, these concerns are not unwarranted.
    [Show full text]
  • Bol-Pharma-Prospectus.Pdf
    A copy of this preliminary prospectus has been filed with the securities regulatory authorities in each of the provinces and territories of Canada but has not yet become final for the purpose of the sale of securities. Information contained in this preliminary prospectus may not be complete and may have to be amended. The securities may not be sold until a receipt for the prospectus is obtained from the securities regulatory authorities. No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus constitutes a public offering of these securities only in those jurisdictions where they may be lawfully offered for sale and therein only by persons permitted to sell such securities. These securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the ‘‘U.S. Securities Act’’), or the securities laws of any state of the United States and may not be offered or sold, directly or indirectly, in the United States or in any other jurisdiction where the offer or sale of such securities is not permitted, except pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws, or securities laws of any other relevant jurisdiction. This prospectus does not constitute an offer to sell or solicitation of an offer to buy any of these securities in any jurisdiction where the offer, sale or solicitation of an offer to buy any of these securities is not permitted. See ‘‘Plan of Distribution’’.
    [Show full text]
  • The Rise and Decline of Cannabis Prohibition the History of Cannabis in the UN Drug Control System and Options for Reform
    TRANSNATIONAL I N S T I T U T E THE RISE AND DECLINE OF CANNABIS PROHIBITION THE HISTORY OF CANNABIS IN THE UN DruG CONTROL SYSTEM AND OPTIONS FOR REFORM 3 The Rise and Decline of Cannabis Prohibition Authors Dave Bewley-Taylor Tom Blickman Martin Jelsma Copy editor David Aronson Design Guido Jelsma www.guidojelsma.nl Photo credits Hash Marihuana & Hemp Museum, Amsterdam/ Barcelona Floris Leeuwenberg Pien Metaal UNOG Library/League of Nations Archives UN Photo Printing Jubels, Amsterdam Contact Transnational Institute (TNI) De Wittenstraat 25 1052 AK Amsterdam Netherlands Tel: +31-(0)20-6626608 Fax: +31-(0)20-6757176 [email protected] www.tni.org/drugs www.undrugcontrol.info www.druglawreform.info Global Drug Policy Observatory (GDPO) Research Institute for Arts and Humanities Rooms 201-202 James Callaghan Building Swansea University Financial contributions Singleton Park, Swansea SA2 8PP Tel: +44-(0)1792-604293 This report has been produced with the financial www.swansea.ac.uk/gdpo assistance of the Hash Marihuana & Hemp Museum, twitter: @gdpo_swan Amsterdam/Barcelona, the Open Society Foundations and the Drug Prevention and Information Programme This is an Open Access publication distributed under (DPIP) of the European Union. the terms of the Creative Commons Attribution License The contents of this publication are the sole responsibility (http://creativecommons.org/licenses/by/2.0), which of TNI and GDPO and can under no circumstances be permits unrestricted use, distribution, and reproduction regarded as reflecting the position of the donors. in any medium, provided the original work is properly cited. TNI would appreciate receiving a copy of the text in which this document is used or cited.
    [Show full text]
  • Cannabis in Africa
    CANNABIS IN AFRICA An Overview November 2007 Cannabis in Africa The overview of the cannabis situation in Africa presented in this document was prepared by Denis Destrebecq in the context of "Data For Africa", the segment of UNODC's Trends Monitoring and Analysis Programme dedicated to Africa and funded by France and Sweden. UNODC reiterates its appreciation to the African Member States who responded to the UN Annual Report Questionnaire on drugs. This questionnaire, together with the data base on individual drug seizures, constitutes the core source of information on drugs for UNODC. The boundaries, names and designations used in all maps in this book do not imply official endorsement or acceptance by the United Nations. This publication has not been formally edited 1 Cannabis in Africa EXECUTIVE SUMMARY: Cannabis in Africa This paper summarizes the latest information available on cannabis in Africa. Information comes from the 2006 and the 2007 editions of the United Nation’s Office on Drugs and Crime’s (UNODC) World Drug Report. The World Drug Report 2006 contains an extended section on the global cannabis situation. The 2006 Report is still available at www.unodc.org or by request at [email protected] . The 2007 World Drug Report, which contains the most recent trends on cannabis in Africa, is available at the same address. The highest levels of cannabis production in the world take place on the African continent. Ten thousand five hundred metric tons or roughly 25 per cent of global production of cannabis herb is estimated to have taken place in Africa in 2005.
    [Show full text]
  • Illicit Drug Policies and Social Outcomes: a Cross- Country Analysis
    ILLICIT DRUG POLICIES AND SOCIAL OUTCOMES: A CROSS- COUNTRY ANALYSIS Final report 31st March 2021 Illicit drug policies and social outcomes: a cross- country analysis Research project funded by the European Research Area Network on Illicit Drugs (ERANID) Project team Principal Investigator (PI) and co-Principal Investigators (co- PI) Ricardo Gonçalves (PI), Católica Porto Business School, Universidade Católica Portuguesa, Portugal Pierre Kopp (co-PI), Université Paris I Panthéon-Sorbonne, France Dirk Korf (co-PI), Faculty of Law, University of Amsterdam, Netherlands Carla Rossi (co-PI), Consorzio per lo sviluppo delle metodologie e delle innovazioni nelle pubbliche amministrazioni (MIPA), Italy Research team France: Marysia Ogrodnik (Université Paris I Panthéon-Sorbonne) Italy: Alessio Canzonetti, Dario Cirillo, Francesca de Marinis, Francesco Fabi and Fabio Massimo Lanzoni (MIPA) Netherlands: Annemieke Benschop, Nienke Liebregts and Kostas Skliamis (University of Amsterdam) Portugal: Ana Lourenço and Hélia Marreiros (Católica Porto Business School, Universidade Católica Portuguesa) Advisors Cláudia Costa Storti, EMCDDA Paul de Grauwe, London School of Economics Mathias Siems, Durham University Jenny Williams, University of Melbourne Please cite as: Gonçalves, R., Kopp, P., Korf, D., Rossi, C., Ogrodnik, M., Canzonetti, A., Cirillo, D., de Marinis, F., Fabi, F., Lanzoni, F. M., Benschop, A., Liebregts, N., Skliamis, K., Lourenço, A. & Marreiros, H. (2021). Illicit drug policies and social outcomes: a cross-country analysis. Final report to ERANID. DISCLAIMER This document is the final report of the IDPSO project funded by ERANID. Any opinions contained in this document should only be attributed to the authors and not to the institutions they are affiliated with. Porto, 31st March 2021 Ricardo Gonçalves Católica Porto Business School | vii TABLE OF CONTENTS 1.
    [Show full text]
  • Safe Cannabis Sales Act of 2019
    1 2 ____________________________ 3 Chairman Phil Mendelson 4 at the request of the Mayor 5 A BILL 6 ______________________ 7 8 IN THE COUNCIL OF THE DISTRICT OF COLUMBIA 9 10 _______________________________________ 11 Chairman Phil Mendelson, at the request of the Mayor, introduced the following bill, 12 which was referred to the Committee on ________________. 13 14 To amend Title 25 of the District of Columbia Official Code to establish the Alcoholic 15 Beverage and Cannabis Board and the Alcoholic Beverage and Cannabis 16 Administration; to establish that the Chairperson of the ABCA Board may also 17 have demonstrated knowledge in the cannabis industry; to define various terms 18 for new chapters 21 through 30; to prohibit the sale of cannabis or cannabis 19 products without a license; to provide the Board with the authority to issue 20 marijuana licenses for 3 year periods; to prohibit exchanges of marijuana for 21 purchasing another item; to create cultivation, manufacturer, distributor, off- 22 premises retailer, and testing facility license categories; to require the Board to 23 consider within 18 months new off-premises and on-premises retailer’s license 24 categories; to require laboratory agent registration with the ABCA; to require 25 persons volunteering or working at cultivation, manufacturer, distributor, and off- 26 premises retailers to obtain a worker’s license; to require off-premises retailers 27 and medical marijuana dispensaries to obtain a delivery endorsement from the 28 Board to deliver cannabis and cannabis products
    [Show full text]
  • US Marijuana Dispensaries Temecula, CA Bars Medical Pot Dispen- Oakland, San Francisco, West Hollywood Goes Up
    CANNABIS HEALTH VOLUME 3 - ISSUE 1 EDITOR BARB ST. JEAN [email protected] The Editor’s Desk................................................... 4 PRODUCTION MANAGER TERESA TAYLOR Off the Web .............................................................................. 4 [email protected] SALES MANAGER Your Turn .................................................................................. 5 LISA SMITH [email protected] Letters to the Editor DISTRIBUTION MANAGER LORRAINE LANGIS [email protected] Sinister Glass............................................................................6 STORE AND SHIPPING MANAGER GORDON TAYLOR Laurie Lee explains what makes her career hot [email protected] ACCOUNTING The Canadian Election Scene.............................................7 BARB CORNELIUS WEBMASTER Former CH Editor, Brian Taylor, on the political scene [email protected] GENERAL INQUIRIES Junkyard Bong Contest ........................................................7 [email protected] Lakota Hemp Days..................................................................8 The Cannabis Health Foundation was formed in the spring of 2002 as a non-profit foundation. Bob Newland, of Hemphasis Magazine, reports Our mandate as a non-profit foundation is to provide accurate up-to-date information on Cannabis Marijuana and Cannabis Hemp in a conservative style magazine that appeals to the general public. We are pleased to Da Kine......................................................................................10
    [Show full text]
  • CAPTURING the MARKET: Cannabis Regulation in Canada
    CAPTURING THE MARKET: Cannabis regulation in Canada 1 Contents Background 5 Responsibilities for Regulation 6 The Federal Regulatory Framework 7 Growing, processing and producing 7 General requirements 8 Cultivation 8 Processing 9 Good production practices 9 Cannabis products 10 Servings and quantities 11 Product safety 11 Sale 12 Retail stores 15 Meeting the market demand 16 Retail locations 19 Online sales 20 Restrictions on sale 21 Purchase limits 21 Sales to particular groups 22 Opening hours and security 23 Advertising and promotion 23 Federal level 23 Provincial level 24 Packaging and design 25 Labelling 26 2 Product information 28 Taxation 28 Price controls 30 Ensuring compliance 31 Record keeping 31 Reporting and inspections 31 Consumption and possession 32 Age access 32 Impaired driving 32 Public consumption 33 Growing cannabis 34 Assessing legal regulation 34 Protecting public health 34 Protecting young people 36 Reducing criminality in the illegal market 36 Price issues 37 Criminal penalties 37 Social justice and equity measures 40 Social equity measures 40 Expungement and record sealing 41 Corporate capture 42 The beneficiaries 43 International corporate capture 43 Cross-sector investment 45 Shaping regulation 46 Compliance with the United Nations drug control treaties 46 Lessons learned 47 3 Further Reading Transform and MUCD have produced a number of other publications on cannabis regulation which we would recommend reading. These include: Altered States: Lessons from US Cannabis Regulation (English only) Modelos de Regulación Legal del Cannabis en Estados Unidos (Spanish only) How to Regulate Cannabis: A Practical Guide Cannabis legalisation in Canada – One year on Cannabis legalisation in Uruguay: public health and safety over private profit Cannabis policy in the Netherlands: moving forwards not backwards Cannabis regulation in Colorado: early evidence defies the critics 4 On 17 October 2018, Canada moved to legally regulate cannabis for non-medical use.
    [Show full text]